The industry is making space for CRAs

For too long, Clinical Research Associates (CRAs) have been seen as the boots on the ground. Vital, yes, but often excluded from the strategic conversations shaping clinical research.

That’s changing.

Across the industry, CRAs are gaining long-overdue recognition as the connective tissue of every clinical trial. They’re not just monitoring data — they’re building and maintaining site relationships, supporting trial conduct, safeguarding data integrity, and ensuring operational excellence. They are the ones bridging the gap between protocol and practice.

Today, more than ever, CRAs are becoming central players in the success of clinical trials.

The CRA role is evolving — and so is the industry’s focus

In recent years, we’ve seen a clear shift:

• Technology companies are designing tools specifically for CRAs — recognizing their complex workflows and day-to-day pressures.
• Sponsors and CROs are investing in CRA training and retention, acknowledging the cost of burnout and turnover.
• Industry forums and task forces are beginning to include CRA voices in shaping monitoring approaches and site engagement models.

CRACONNECT LIVE 2026 is a continuation of this momentum — but also a bold next step:

It’s the first time the industry gathers for and with CRAs.

Why Sponsors Care

This isn’t just a feel-good initiative — it’s a strategic one.

By partnering with CRACONNECT LIVE 2026, you are:

• Positioning your brand at the forefront of CRA empowerment
• Engaging directly with the professionals who use your systems, represent your studies, and uphold your reputation at the site level
• Supporting better recruitment, retention, and relationship-building with the very people who carry your trials forward

CRAs are fast becoming one of the most critical levers for trial quality, site performance, and innovation adoption.

The clinical research industry is finally making space for them.

Now’s the time to step in and show your support.

Join us in Barcelona, May 12–13, 2026.
Let’s build the future of clinical research — with CRAs, not without them.